XML 101 R82.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed consolidating financial statements - Condensed Consolidating Statements of Operations (Detail) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Condensed Income Statements Captions [Line Items]        
Dialysis and related lab patient service revenues $ 2,718,403,000 $ 2,494,609,000 $ 5,309,477,000 $ 4,917,395,000
Less: Provision for uncollectible accounts (49,406,000) (109,600,000) (23,861,000) (216,658,000)
Net dialysis and related lab patient service revenues 2,668,997,000 2,385,009,000 5,285,616,000 4,700,737,000
Other revenues 217,956,000 314,390,000 450,781,000 629,913,000
Total revenues 2,886,953,000 2,699,399,000 5,736,397,000 5,330,650,000
Operating expenses and charges 2,448,761,000 2,308,203,000 4,887,519,000 4,063,526,000
Operating income 438,192,000 391,196,000 848,878,000 1,267,124,000
Debt expense (119,692,000) (107,934,000) (233,208,000) (212,331,000)
Other income, net 1,994,000 4,798,000 6,576,000 8,784,000
Income tax expense 83,868,000 101,915,000 154,605,000 383,580,000
Equity (loss) earnings in subsidiaries 0 0 0 0
Net income from continuing operations 236,626,000 186,145,000 467,641,000 679,997,000
Net income (loss) from discontinued operations, net of tax 69,696,000 (24,520,000) 63,910,000 (18,087,000)
Net income 306,322,000 161,625,000 531,551,000 661,910,000
Less: Net income attributable to noncontrolling interests (39,046,000) (34,624,000) (85,589,000) (87,212,000)
Net income attributable to DaVita Inc. 267,276,000 127,001,000 445,962,000 574,698,000
Consolidating adjustments        
Condensed Income Statements Captions [Line Items]        
Dialysis and related lab patient service revenues (49,788,000) (39,601,000) (97,303,000) (76,772,000)
Less: Provision for uncollectible accounts 0 0 0 0
Net dialysis and related lab patient service revenues (49,788,000) (39,601,000) (97,303,000) (76,772,000)
Other revenues (244,764,000) (200,349,000) (483,397,000) (427,920,000)
Total revenues (294,552,000) (239,950,000) (580,700,000) (504,692,000)
Operating expenses and charges (294,552,000) (239,950,000) (580,700,000) (504,692,000)
Operating income 0 0 0 0
Debt expense 62,759,000 59,380,000 123,149,000 117,522,000
Other income, net (110,646,000) (104,867,000) (218,372,000) (207,607,000)
Income tax expense 0 0 0 0
Equity (loss) earnings in subsidiaries (428,691,000) (181,457,000) (636,303,000) (738,574,000)
Net income from continuing operations (476,578,000) (226,944,000) (731,526,000) (828,659,000)
Net income (loss) from discontinued operations, net of tax 47,887,000 45,487,000 95,223,000 90,085,000
Net income (428,691,000) (181,457,000) (636,303,000) (738,574,000)
Less: Net income attributable to noncontrolling interests (39,046,000) (34,624,000) (85,589,000) (87,212,000)
Net income attributable to DaVita Inc. (467,737,000) (216,081,000) (721,892,000) (825,786,000)
DaVita Inc. | Reportable Legal Entities        
Condensed Income Statements Captions [Line Items]        
Dialysis and related lab patient service revenues 0 0 0 0
Less: Provision for uncollectible accounts 0 0 0 0
Net dialysis and related lab patient service revenues 0 0 0 0
Other revenues 205,317,000 193,585,000 400,882,000 414,971,000
Total revenues 205,317,000 193,585,000 400,882,000 414,971,000
Operating expenses and charges 145,649,000 138,104,000 279,005,000 270,014,000
Operating income 59,668,000 55,481,000 121,877,000 144,957,000
Debt expense (120,814,000) (106,159,000) (235,148,000) (208,823,000)
Other income, net 105,344,000 102,299,000 209,425,000 202,636,000
Income tax expense 13,257,000 20,528,000 27,644,000 54,481,000
Equity (loss) earnings in subsidiaries 236,335,000 95,908,000 377,452,000 490,409,000
Net income from continuing operations 267,276,000 127,001,000 445,962,000 574,698,000
Net income (loss) from discontinued operations, net of tax 0 0 0 0
Net income 267,276,000 127,001,000 445,962,000 574,698,000
Less: Net income attributable to noncontrolling interests 0 0 0 0
Net income attributable to DaVita Inc. 267,276,000 127,001,000 445,962,000 574,698,000
Guarantor subsidiaries | Reportable Legal Entities        
Condensed Income Statements Captions [Line Items]        
Dialysis and related lab patient service revenues 1,831,545,000 1,654,430,000 3,621,733,000 3,185,156,000
Less: Provision for uncollectible accounts (27,159,000) (72,845,000) (17,531,000) (133,898,000)
Net dialysis and related lab patient service revenues 1,804,386,000 1,581,585,000 3,604,202,000 3,051,258,000
Other revenues 214,266,000 305,319,000 419,226,000 610,937,000
Total revenues 2,018,652,000 1,886,904,000 4,023,428,000 3,662,195,000
Operating expenses and charges 1,850,377,000 1,682,483,000 3,641,471,000 2,891,303,000
Operating income 168,275,000 204,421,000 381,957,000 770,892,000
Debt expense (52,363,000) (48,117,000) (104,560,000) (95,760,000)
Other income, net 2,856,000 1,369,000 5,379,000 4,172,000
Income tax expense 40,019,000 71,299,000 88,962,000 307,165,000
Equity (loss) earnings in subsidiaries 192,356,000 85,549,000 258,851,000 248,165,000
Net income from continuing operations 271,105,000 171,923,000 452,665,000 620,304,000
Net income (loss) from discontinued operations, net of tax (34,770,000) (76,015,000) (75,213,000) (129,895,000)
Net income 236,335,000 95,908,000 377,452,000 490,409,000
Less: Net income attributable to noncontrolling interests 0 0 0 0
Net income attributable to DaVita Inc. 236,335,000 95,908,000 377,452,000 490,409,000
Non- Guarantor subsidiaries | Reportable Legal Entities        
Condensed Income Statements Captions [Line Items]        
Dialysis and related lab patient service revenues 936,646,000 879,780,000 1,785,047,000 1,809,011,000
Less: Provision for uncollectible accounts (22,247,000) (36,755,000) (6,330,000) (82,760,000)
Net dialysis and related lab patient service revenues 914,399,000 843,025,000 1,778,717,000 1,726,251,000
Other revenues 43,137,000 15,835,000 114,070,000 31,925,000
Total revenues 957,536,000 858,860,000 1,892,787,000 1,758,176,000
Operating expenses and charges 747,287,000 727,566,000 1,547,743,000 1,406,901,000
Operating income 210,249,000 131,294,000 345,044,000 351,275,000
Debt expense (9,274,000) (13,038,000) (16,649,000) (25,270,000)
Other income, net 4,440,000 5,997,000 10,144,000 9,583,000
Income tax expense 30,592,000 10,088,000 37,999,000 21,934,000
Equity (loss) earnings in subsidiaries 0 0 0 0
Net income from continuing operations 174,823,000 114,165,000 300,540,000 313,654,000
Net income (loss) from discontinued operations, net of tax 56,579,000 6,008,000 43,900,000 21,723,000
Net income 231,402,000 120,173,000 344,440,000 335,377,000
Less: Net income attributable to noncontrolling interests 0 0 0 0
Net income attributable to DaVita Inc. $ 231,402,000 $ 120,173,000 $ 344,440,000 $ 335,377,000